Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.
about
New advances in hepatocellular carcinomaHepatitis C and Innate Immunity: Recent AdvancesOxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesisInvolvement of DNA damage response pathways in hepatocellular carcinoma.Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinomaTargeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatmentRole of MicroRNAs in Hepatocellular CarcinomaMolecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?Single nucleotide polymorphisms of microRNA processing machinery genes and outcome of hepatocellular carcinoma.Alcohol and hepatitis C virus--interactions in immune dysfunctions and liver damage.Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma.SNP rs2057482 in HIF1A gene predicts clinical outcome of aggressive hepatocellular carcinoma patients after surgery.8-Hydroxy-2'-deoxyguanosine expression predicts hepatocellular carcinoma outcomeTumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma.Meta-analysis of the correlation between selenium and incidence of hepatocellular carcinomaMitochondrial DNA haplogroup M is associated with late onset of hepatocellular carcinomaCharacteristic expression pattern of oxidative stress in livers with cryptogenic hepatocellular carcinomaHepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C.Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stressPotential biomarkers of ageing.Interactions Between Hepatitis C Virus and Mitochondria: Impact on Pathogenesis and Innate Immunity.Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma.Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?HCV and oxidative stress in the liver.Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.Redox regulation of inflammation: old elements, a new story.Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.Mutations in hepatitis B virus small S genes predict postoperative survival in hepatocellular carcinoma.Prognostic value of red blood cell distribution width in hepatocellular carcinoma.Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study.Preoperative transcatheter arterial chemotherapy may suppress oxidative stress in hepatocellular carcinoma cells and reduce the risk of short-term relapse.Circulating Biomarkers and their Possible Role in Pathogenesis of Chronic Hepatitis B and C Viral Infections.X protein mutations in hepatitis B virus DNA predict postoperative survival in hepatocellular carcinoma.A polymorphism at the microRNA binding site in the 3' untranslated region of RYR3 is associated with outcome in hepatocellular carcinoma.HCV-related proteins activate Kupffer cells isolated from human liver tissues.Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carciA polymorphism at the miR-502 binding site in the 3'-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome.Metabolite target analysis of human urine combined with pattern recognition techniques for the study of symptomatic gout.Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test.
P2860
Q26749329-FD699792-3268-47F8-BF90-7243BBD5EA73Q27487394-1E4D107A-3B4A-4802-A834-6882AAD0010DQ28075646-A7AF6EC2-179A-4994-BEAD-0A80E6C28A84Q33616812-620227E8-78EB-450E-A73D-F3AF2CB9E745Q33797504-3F2129E7-5802-49C2-9FB2-1AC3EB8F5513Q34347862-419EDD58-FDCE-48F4-B135-03C65E560E4EQ34348824-5185763E-DA73-4FE2-A3A7-1D08BB2041E3Q35048768-75BFAD7D-DF22-48F8-98FC-FBF9A3B983EFQ35133706-EBEE6790-CF86-4540-BFBA-07D20B3AB665Q35660303-AB21DCC8-731F-464A-A256-8683E0E9F21FQ35711706-9019F1A1-355F-47FA-A4B2-A4CED911C857Q35785191-96ABCA40-DF55-4F82-BF9B-4C5737B2A1C3Q35995355-0269B433-2C4F-4E15-851B-67D28B92299BQ36143638-CF4F011E-66F3-4CFC-B17D-AB2ED1CC3E9CQ36174323-E694DD12-765C-48EA-A5C8-0722C57C5D2CQ36224454-5C299F71-E55B-4CF3-9069-08883314759CQ36244269-78246B73-605D-4ED6-BEAE-CC5ABDF70F44Q36459759-62E91B81-A59F-447F-BB1F-7FFC31C73150Q36946710-9BDA1547-D71F-424F-B435-FDD700394D0CQ37061417-66D92F87-C7C7-4515-81B7-559518862A25Q37095314-1DEA4B57-C318-465C-AAE4-5C9ABB769395Q37359619-98A2218B-DC7D-4E43-ADAB-7FDEA88A79E4Q37932057-0DEE310E-4010-4489-8076-D3C69E527D73Q38077447-9D5FC17B-702D-46F7-B9B1-D72D34C65006Q38157936-45CA08C5-6769-45E3-9CC4-32346D14B872Q38244572-2356F3B4-81FB-4F48-85BB-87AC3B8A19B8Q38613525-47DE2250-7978-4B44-A155-73B90523D87EQ39439263-563B75A9-8B6F-4797-8BBC-4DFF9D3AC7A6Q40422810-30EAA79E-814B-495C-B129-5FF3A89A66CDQ41050154-7903EBC7-9418-4645-9B3B-AE5A914D1E65Q41518664-E763644E-F001-4451-A40D-D6E556B81F2DQ41552085-FB8472A6-E329-4629-896E-9C11CA3E804BQ42128346-9C02BBDC-C827-412D-A00F-E0FCF3DCCE30Q42205637-B9437127-6D79-4824-A5A8-B1FCA47E0594Q42557917-C0F76FBE-520F-49B4-8562-B1155764D41AQ42999998-E70D113F-5BB8-4B85-82A4-A9232D6DD3CCQ43591529-7E02CD43-2F35-49BD-A8FD-899ABAC609ACQ43849549-8E3E6792-0D68-4D22-90B6-111395518685Q44795321-52A83361-EA65-43DA-A4DF-99E76BF39586Q45247507-BF2CFFEE-1263-46BE-8670-325813B00081
P2860
Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Predictive power of biomarkers ...... ated hepatocellular carcinoma.
@en
Predictive power of biomarkers ...... ated hepatocellular carcinoma.
@nl
type
label
Predictive power of biomarkers ...... ated hepatocellular carcinoma.
@en
Predictive power of biomarkers ...... ated hepatocellular carcinoma.
@nl
prefLabel
Predictive power of biomarkers ...... ated hepatocellular carcinoma.
@en
Predictive power of biomarkers ...... ated hepatocellular carcinoma.
@nl
P2093
P1476
Predictive power of biomarkers ...... ated hepatocellular carcinoma.
@en
P2093
Akira Maki
Hideki Fujii
Hiroshi Kono
Ivan Rusyn
Masami Asakawa
Masanori Matsuda
Mayetri Gupta
Tetsuya Suzuki
P2888
P304
P356
10.1245/S10434-006-9049-1
P577
2007-03-01T00:00:00Z
P5875
P6179
1046212581